An overview of thromboprophylaxis in malignancy.
Kakkar
A K
AK
Hammersmith Hospital, Imperial College, Thrombosis Research Institute, London, England, UK. akkakkar@tri-london.ac.uk
D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use; D006801:Humans; D009369:Neoplasms / Q000150:complications* / Q000628:therapy; D013923:Thromboembolism / Q000209:etiology / Q000517:prevention & control*; D020246:Venous Thrombosis / Q000209:etiology / Q000517:prevention & control*
D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight